Allianz’s AstraZeneca AZN Stock Holding History

Allianz’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	79,986 +13,738	+21%	+$2.58M	0.16%	79
2026 Q1	$12.8M	Buy	66,248 +61,801	+1,390%	+$11.9M	0.14%	88
2025 Q4	$818K	Buy	4,447 +742	+20%	+$130K	0.01%	268
2025 Q3	$568K	Buy	3,705 +95	+3%	+$14.4K	0.01%	257
2025 Q2	$504K	Buy	3,610 +2,158	+149%	+$302K	0.01%	246
2025 Q1	$213K	Buy	+1,452	New	+$210K	0.01%	307

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Allianz's AZN Position: Q2 2026 in Review

Allianz increased its AstraZeneca (AZN) stake by 21% in Q2 2026, buying an estimated $2.58M and bringing the position to 79,986 shares worth $15M. The position accounts for 0.16% of the portfolio, ranked #79.

Allianz first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Allianz held 79,986 shares of AstraZeneca worth $15M as of Q2 2026.
Allianz bought 13,738 AstraZeneca shares in Q2 2026, an estimated $2.58M.
AstraZeneca made up 0.16% of Allianz's portfolio in Q2 2026, its #79 holding.
Allianz first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.